Abstract: In one aspect, the invention relates to substituted 1H-benzo[d][1,2,3]triazol-1-ol analgoues, derivatives thereof, and related compound; synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating disorders, e.g. various tumors and cancers, associated with ?-catenin/Tcf protein-protein interaction dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Abstract: Power management methods, apparatus and articles of manufacture for audience measurement meters are disclosed. An example method disclosed herein comprises determining an activation state of a media presentation device, and controlling activation of an audience measurement meter based on the activation state of the media presentation device, the audience measurement meter to monitor the media presentation device when the activation state is an active state. Another example method disclosed herein comprises obtaining presentation device state data representing an activation state of a media presentation device to be monitored by an audience measurement meter, the presentation device state data including time information, and determining whether to fault audience measurement data reported by the audience measurement meter based on the presentation device state data and outage information determined from the audience measurement data.

Abstract: This invention belongs to the field of biochemical engineering and relates to a method of cyclic utilization of water during separation of succinic acid made by fermentation. This invention uses water from separation process for aerobic growth of E.coli AFP111 and production of succinic acid by anaerobic fermentation, obtaining final succinic acid concentration of 55 g/L and yield of 91.6%. Compared with results of fermentation using culture medium prepared from tap water, succinic acid concentration and productivity increased by 8.5% and 8.46%, respectively. An outstanding advantage of this invention is recovery and utilization of evaporated water during separation of succinic acid, realizing cyclic use of water during industrial production of succinic acid, which is an environment-friendly process.

Abstract: Disclosed herein are biocatalysts for the production of biofuels, including microorganisms that contain genetic modifications conferring tolerance to growth and fermentation inhibitors found in many cellulosic feedstocks. Methods of converting cellulose-containing materials to fuels and chemicals, as well as methods of fermenting sugars to fuels and chemicals, using these biocatalysts are also disclosed.

Abstract: Critical resources are identified within a computer system such as operating system files, drivers, modules and registry keys that are used to bootstrap the computer. During a successful bootstrap, these resources are saved into persistent storage during the bootstrap phase. Changes to critical resources are monitored and these resources are backed up if they are changed. Upon computer system failure, steps of identifying the type of failure and an analysis of its root cause are optionally performed. A user is presented with a bootstrap menu and critical resources necessary to bootstrap the computer are retrieved from persistent storage and saved into their appropriate locations. A successful bootstrap is then performed of the computer system in order to recover from the failure.

Abstract: The present application relates to nitrogen-containing fused ring compounds shown by general formula (I), a pharmaceutically acceptable salt thereof and a stereoisomer thereof as CRTH2 antagonist, wherein X1, X2, X3, X4, X5, W, X, Y, L1, L2, L3, A, B are as defined in the description; the present application further relates to a method for preparing the compounds, a pharmaceutical formulation and a pharmaceutical composition comprising the compounds, a use of the compounds for the manufacture of a medicament for the treatment and/or prevention of diseases related to activity of CRTH2.

Abstract: The present application relates to aryl- and heteroaryl-fused decahydropyrroloazepine, octahydrooxepinopyrrole, octahydropyrrolothiazepine dioxide, decahydrocyclohepta[c]pyrrole, and octahydrocyclohepta[c]pyrrole derivatives of formula (I) wherein R1, R2, R3, R4, R5, A, Y1, Y2, and Y3 are as defined in the specification. The present application also relates to compositions comprising such compounds, processes for making such compounds, and methods of treating disease conditions using such compounds and compositions, and methods for identifying such compounds.

Abstract: An L-arabinose utilizing yeast strain is provided for the production of ethanol by introducing and expressing bacterial araA, araB and araD genes. L-arabinose transporters are also introduced into the yeast to enhance the uptake of arabinose. The yeast carries additional genomic mutations enabling it to consume L-arabinose, even as the only carbon source, and to produce ethanol. A yeast strain engineered to metabolize arabinose through a novel pathway is also disclosed. Methods of producing ethanol include utilizing these modified yeast strains.

Abstract: Nanoparticles having one or more attached sensing moieties including uridine 5?-triphosphate (UTP) and deoxythymidine 5?-triphosphate (dTTP), are disclosed herein. These nanoparticles can, for example, be used for detection of plasticizers, such as phthalates, in the sample. Methods, kits and apparatuses using these nanoparticles for detecting plasticizers in a sample are also disclosed herein.

Abstract: This invention discloses a novel compound with the structure of formula I, or pharmaceutically acceptable salts or solvates thereof. In addition, the invention further discloses a method for preparing the compound, a pharmaceutical composition containing the compound, and use thereof in the preparation of a hypoglycemic medicament.

Abstract: A display adjustment method, system and electronic device. The method comprises: determining whether a touch sensing unit generates a color cast to obtain a first determination result; when the touch sensing unit generates a color cast, determining whether the color cast meets a preset condition to obtain a second determination result; and when the second determination result indicates that the color cast meets the preset condition, adjusting display parameters of a display unit based on the color cast, so as to correct the color cast. The technical solution provided in the embodiment of the disclosure can effectively correct the problem of the color cast of the display screen caused by a reason such as the used material or display structure and enhance the display effect.

Abstract: The present invention relates to benzenesulfonyl or sulfonamide compounds of formulae IA and IB wherein the variables have the meanings given in the claims and the description, pharmaceutical compositions containing them, and their use in therapy. The compounds possess valuable therapeutic properties and are particularly suitable for treating diseases that respond to modulation of the serotonin 5-HT6 receptor.

Abstract: A process for producing formic acid by hydrothermal oxidation reaction with glycerol and their equipment, wherein glycerol and oxidant are subjected to a hydrothermal oxidation reaction, air, oxygen or H2O2 as oxidant, at a temperature in the range of 150 to 450° C. and under pressure equal to or more than the saturated vapor pressure at the temperature. The glycerol produced from plant fats, animal fats or the like or pure product synthesized chemically or a discharge containing glycerol generated at the production of diesel fuel oil from fats, in which the fats are subjected to a transesterification with alcohol in the presence of an alkali catalyst in order to obtain fatty acid ester is preferably used as a starting material.

Abstract: In accordance with a first exemplary embodiment of the present disclosure, a mounting arrangement for use with an LED power strip module is provided. The mounting arrangement comprises one or more one frames having a first end and a second end, a first holding base configured to mate with the first end and a second holding base configured to mate with the second end, and at least one LED module having a first and second edge and comprising a plurality of LEDs, said LED module being adapted to removably attach to the one or more frames. The first and second holding bases are adapted to secure the one or more frames to an existing raceway structure.

Abstract: An apparatus for measuring a position deviation of a rotor of a permanent magnet synchronous motor includes a control unit, a power transformation unit, a rotor position estimator and a calculation unit. The control unit receives a d-axis DC voltage signal and a q-axis AC voltage signal and receives an initial value of the rotor position and a high-frequency signal to output a three-phase command signal. The power transformation unit receives the three-phase command signal and outputs a three-phase control signal for controlling the motor. The rotor position estimator receives a three-phase current feedback signal corresponding to an operation of the motor and generates an estimation value of the rotor position. The calculation unit performs calculation to the initial value and the estimation value to generate a deviation value of the rotor position. Moreover, a method for measuring the position deviation is also disclosed herein.

Abstract: Embodiments of the present invention disclose a mask plate and a manufacturing method thereof. The mask plate includes a mask plate body and a transmissive member, wherein the mask plate body has a transmissive part and a non-transmissive part adjacent to the transmissive part, the transmissive member is disposed corresponding to the transmissive part of the mask plate body, the absorbance of the transmissive member progressively increases in a direction away from a center region of the transmissive member to a edges region of the transmissive member close to the non-transmissive part.

Abstract: The present invention relates to N-Phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds of formula I wherein the variables have the meanings given in the claims and the description, pharmaceutical compositions containing them, and their use in therapy. The compounds possess valuable therapeutic properties and are particularly suitable for treating diseases that respond to modulation of the serotonin 5-HT6 receptor.

Abstract: A thermal interface material provides thermal conduction or thermal dissipation across an interface, using a three-dimensional interconnected porous graphene (3D-IPG) foam structure. The 3D-IPG foam structure is constructed of three-dimensional interconnected graphene sheets formed as a plurality of monolayers, and having an flexible interconnection architecture. The flexible interconnection architectures allow the 3D-IPG to maintain a high interfacial thermal conductance by the 3D-IPG filling a gap between a heat source and a heat sink across the interface, and by capping small features up to nanoscale roughened surfaces.

Abstract: An outer layer having an entanglement comprising an intermingling of cloaked hydrophilic guest and a hydrophobic polymer host, wherein molecules of the guest have been crosslinked with each other. Under certain circumstances, using complexes of the guest may be desirable or even necessary. The intermingling of the guest and host includes a physical tangling, whether it also comprises crosslinking by primary bonding (e.g., chemical/covalent bonding) there-between. Also a method of producing an outer layer having such an entanglement, including the steps of: temporarily cloaking at least a portion of the hydrophilic groups of the guest; intermingling at least a portion of the cloaked groups with a porous polymeric structure by diffusing the guest with cloaked groups into at least a portion of the structure's pores; within the pores, crosslinking at least a portion of the molecules of the guest with the guest; and removing the cloaking. Cloaking may be performed by silylation or acylation.

Abstract: The present disclosure provides, inter alia, a method of producing an outer layer material for forming into a structure and that comprises an entanglement having a hydrophobic polymer host and a hydrophilic guest, including in one embodiment the steps of: intermingling cloaked hydrophilic guest complexes with the hydrophobic host; crosslinking molecules of the guest with the guest; and performing a hydrolysis reaction.